Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients (Q38391209)

2 September 2017

title

Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients (English)

1 reference

2 September 2017

main subject

anti-retroviral agent

0 references

1 reference

Christoph Stephan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Hanna-Mari Baldauf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Joanne Barry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Frank A Giordano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Cynthia C Bartholomae

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Annette Haberl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Markus Bickel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Stephanie Laufs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Oliver T Keppler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

23 June 2014

1 reference

Journal of Antimicrobial Chemotherapy

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

2809-2818

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV inf

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Determining the relative efficacy of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Virus dynamics and drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

The role of unintegrated DNA in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Clinical use of HIV integrase inhibitors: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

A quantitative assay for HIV DNA integration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Restoration of the immune system with anti-retroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Stem-cell gene therapy for the Wiskott-Aldrich syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU213

21 January 2018

Identifiers

DOI

10.1093/JAC/DKU213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json

release_eapxsslaifb5hjaaohkn5mya6m

9 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eapxsslaifb5hjaaohkn5mya6m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24962031%20AND%20SRC:MED&resulttype=core&format=json